SELLAS Life Sciences Group, Inc

Historical 13F Holders

Symbol
SLS
CUSIP
81642T209
All holders as of
Q2 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 86 26.8 M $58.6 M
2025 Q1 50 14.3 M $15.4 M
2024 Q4 36 6.20 M $6.44 M
2024 Q3 39 5.39 M $6.74 M
2024 Q2 37 4.06 M $4.83 M
2024 Q1 38 7.73 M $7.80 M
2023 Q4 38 3.50 M $3.71 M
2023 Q3 32 2.75 M $4.51 M
2023 Q2 29 3.11 M $4.89 M
2023 Q1 28 3.00 M $4.28 M
2022 Q4 36 1.96 M $4.63 M
2022 Q3 36 2.19 M $4.42 M
2022 Q2 34 2.98 M $6.64 M
2022 Q1 35 1.69 M $11.3 M
2021 Q4 35 1.83 M $10.1 M
2021 Q3 36 1.86 M $17.1 M
2021 Q2 40 1.90 M $21.3 M
2021 Q1 40 1.55 M $13.3 M
2020 Q4 26 941 k $5.46 M
2020 Q3 15 617 k $1.63 M
2020 Q2 17 456 k $1.34 M
2020 Q1 17 417 k $722 k
2019 Q4 14 441 k $1.89 M
2019 Q3 1 3.00 $0
2019 Q2 1 3.00 $0
2019 Q1 1 3.00 $0